Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
Several neurodegenerative diseases, including Parkinson's disease (PD) are associated with protein misfolding and the formation of distinct aggregates, resulting in a putative pathological protein load on the nervous system. A variety of factors cause proteins to aggregate, including aggregation-prone sequences, specific mutations, protein modifications and also dysregulation of the protein degradation machinery. Molecular chaperones are responsible for maintaining normal protein homeostasis within the cell by assisting protein folding and modulating protein-degrading pathways. Here, we review the fundamental mechanisms of neurodegeneration occurring in PD involving alpha-synuclein fibrillisation and aggregation, endoplasmic reticulum stress, ubiquitin proteasome systems, autophagy and lysosomal degradation. Molecular chaperones serve a neuroprotective role in many of these pathways, and we discuss recent evidence indicating that these proteins might provide the basis for new therapeutic approaches.
Bandopadhyay
Rina
R
Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London, London, UK. regtrib@ucl.ac.uk
de Belleroche
Jacqueline
J
D000818:Animals; D006801:Humans; D018832:Molecular Chaperones / Q000235:genetics / Q000378:metabolism*; D010300:Parkinson Disease / Q000235:genetics / Q000378:metabolism*; D017510:Protein Folding; D051844:alpha-Synuclein / Q000235:genetics / Q000378:metabolism
D018832:Molecular Chaperones; D051844:alpha-Synuclein